310 related articles for article (PubMed ID: 27624963)
1. 6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.
Liao G; Zhou Z; Liao J; Zu L; Wu Q; Guo Z
ACS Infect Dis; 2016 Feb; 2(2):123-31. PubMed ID: 27624963
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and immunological studies of linear oligosaccharides of β-glucan as antigens for antifungal vaccine development.
Liao G; Zhou Z; Burgula S; Liao J; Yuan C; Wu Q; Guo Z
Bioconjug Chem; 2015 Mar; 26(3):466-76. PubMed ID: 25671314
[TBL] [Abstract][Full Text] [Related]
3. Beta-glucan-CRM197 conjugates as candidates antifungal vaccines.
Bromuro C; Romano M; Chiani P; Berti F; Tontini M; Proietti D; Mori E; Torosantucci A; Costantino P; Rappuoli R; Cassone A
Vaccine; 2010 Mar; 28(14):2615-23. PubMed ID: 20096763
[TBL] [Abstract][Full Text] [Related]
4. Hyr1 protein and β-glucan conjugates as anti-Candida vaccines.
Cassone A; Bromuro C; Chiani P; Torosantucci A
J Infect Dis; 2010 Dec; 202(12):1930. PubMed ID: 21083372
[No Abstract] [Full Text] [Related]
5. A novel glyco-conjugate vaccine against fungal pathogens.
Torosantucci A; Bromuro C; Chiani P; De Bernardis F; Berti F; Galli C; Norelli F; Bellucci C; Polonelli L; Costantino P; Rappuoli R; Cassone A
J Exp Med; 2005 Sep; 202(5):597-606. PubMed ID: 16147975
[TBL] [Abstract][Full Text] [Related]
6. A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique.
Pietrella D; Rachini A; Torosantucci A; Chiani P; Brown AJ; Bistoni F; Costantino P; Mosci P; d'Enfert C; Rappuoli R; Cassone A; Vecchiarelli A
Vaccine; 2010 Feb; 28(7):1717-25. PubMed ID: 20038431
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine.
Wu X; Lipinski T; Carrel FR; Bailey JJ; Bundle DR
Org Biomol Chem; 2007 Nov; 5(21):3477-85. PubMed ID: 17943207
[TBL] [Abstract][Full Text] [Related]
8. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
[TBL] [Abstract][Full Text] [Related]
9. Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade.
Polonelli L; Beninati C; Teti G; Felici F; Ciociola T; Giovati L; Sperindè M; Lo Passo C; Pernice I; Domina M; Arigò M; Papasergi S; Mancuso G; Conti S; Magliani W
PLoS One; 2014; 9(8):e105727. PubMed ID: 25162681
[TBL] [Abstract][Full Text] [Related]
10. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.
Torosantucci A; Chiani P; Bromuro C; De Bernardis F; Palma AS; Liu Y; Mignogna G; Maras B; Colone M; Stringaro A; Zamboni S; Feizi T; Cassone A
PLoS One; 2009; 4(4):e5392. PubMed ID: 19399183
[TBL] [Abstract][Full Text] [Related]
11. Adjuvanticity of a recombinant calreticulin fragment in assisting anti-β-glucan IgG responses in T cell-deficient mice.
Li WJ; Long K; Dong HL; Gao XM
Clin Vaccine Immunol; 2013 Apr; 20(4):582-9. PubMed ID: 23408527
[TBL] [Abstract][Full Text] [Related]
12. A Convergent Synthesis of 6-
Liao G; Burgula S; Zhou Z; Guo Z
European J Org Chem; 2015 May; 2015(13):2942-2951. PubMed ID: 26257577
[TBL] [Abstract][Full Text] [Related]
13. Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis.
Kondori N; Edebo L; Mattsby-Baltzer I
Clin Diagn Lab Immunol; 2004 Mar; 11(2):344-50. PubMed ID: 15013986
[TBL] [Abstract][Full Text] [Related]
14. A novel monoclonal antibody recognizing beta(1-3) glucans in intact cells of Candida and Cryptococcus.
Kondori N; Edebo L; Mattsby-Baltzer I
APMIS; 2008 Oct; 116(10):867-76. PubMed ID: 19132980
[TBL] [Abstract][Full Text] [Related]
15. The (1->6)-β-glucan moiety represents a cross-reactive epitope of infection-induced malignancy surveillance.
Dong H; Dai H; Hu X; Xiong SD; Gao XM
J Immunol; 2014 Feb; 192(3):1302-12. PubMed ID: 24391208
[TBL] [Abstract][Full Text] [Related]
16. Novel mouse monoclonal antibodies specifically recognizing β-(1→3)-D-glucan antigen.
Matveev AL; Krylov VB; Khlusevich YA; Baykov IK; Yashunsky DV; Emelyanova LA; Tsvetkov YE; Karelin AA; Bardashova AV; Wong SSW; Aimanianda V; Latgé JP; Tikunova NV; Nifantiev NE
PLoS One; 2019; 14(4):e0215535. PubMed ID: 31022215
[TBL] [Abstract][Full Text] [Related]
17. A Three Component Synthetic Vaccine Containing a β-Mannan T-Cell Peptide Epitope and a β-Glucan Dendritic Cell Ligand.
Bundle DR; Paszkiewicz E; Elsaidi HRH; Mandal SS; Sarkar S
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082627
[TBL] [Abstract][Full Text] [Related]
18. Model alpha-mannoside conjugates: immunogenicity and induction of candidacidal activity.
Paulovicová L; Bystrický S; Paulovicová E; Karelin AA; Tsvetkov YE; Nifantiev NE
FEMS Immunol Med Microbiol; 2010 Apr; 58(3):307-13. PubMed ID: 20113351
[TBL] [Abstract][Full Text] [Related]
19. Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.
Xin H; Cartmell J; Bailey JJ; Dziadek S; Bundle DR; Cutler JE
PLoS One; 2012; 7(4):e35106. PubMed ID: 22563378
[TBL] [Abstract][Full Text] [Related]
20. Anti-beta-glucan antibodies in healthy human subjects.
Chiani P; Bromuro C; Cassone A; Torosantucci A
Vaccine; 2009 Jan; 27(4):513-9. PubMed ID: 19041357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
